nach oben

Der Nervenarzt

Erschienen in:

01.10.2006 | Übersichten

Poststroke-Depression

Klinik, Epidemiologie, Therapie, pathophysiologische Konzepte

verfasst von: G. Kronenberg, J. Katchanov, Prof. Dr. M. Endres

Erschienen in: Der Nervenarzt | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Zusammenfassung

Poststroke-Depression (PSD) ist die häufigste psychiatrische Komplikation nach Schlaganfall (bis zu 50%) und ist sowohl für schlaganfallassoziierte Morbidität als auch Mortalität relevant. Vermutlich wird die PSD in der klinischen Praxis zu selten diagnostiziert und häufig nicht adäquat behandelt. Diese Übersichtsarbeit fasst den gegenwärtigen Kenntnisstand zu Epidemiologie, Klinik, Prädisposition und Risikofaktoren, Therapie und Prophylaxe sowie pathophysiologischen Konzepten zusammen.

Aben I, Verhey F, Strik J et al. (2003) A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry 74(5): 581–585 CrossRefPubMed

Alexopoulos GS, Meyers BS, Young RC et al. (1997) ‘Vascular depression‘ hypothesis. Arch Gen Psychiatry 54(10): 915–922PubMed

Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25(6): 1099–1104PubMed

Astrom M (1996) Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke 27(2): 270–275PubMed

Berg A, Palomaki H, Lehtihalmes M et al. (2003) Poststroke depression: an 18-month follow-up. Stroke 34(1): 138–143CrossRefPubMed

Berton O, McClung CA, Dileone RJ et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762): 864–868CrossRefPubMed

Bhogal SK, Teasell R, Foley N et al. (2005) Heterocyclics and selective serotonin reuptake inhibitors in treatment and prevention of poststroke depression. J Am Geriatr Soc 53(6): 1051–1057CrossRefPubMed

Biran I, Chatterjee A (2003) Depression with anosognosia following a left subcortical stroke. Clin Neurol Neurosurg 105(2): 99–101CrossRefPubMed

Boden-Albala B, Litwak E, Elkind MS et al. (2005) Social isolation and outcomes poststroke. Neurology 64(11): 1888–1892CrossRefPubMed

10.

Bozikas VP, Gold G, Kovari E et al. (2005) Pathological correlates of poststroke depression in elderly patients. Am J Geriatr Psychiatry 13(2): 166–169CrossRefPubMed

11.

Bruce EC, Musselman DL (2005) Depression, alterations of platelet function, and ischemic heart disease. Psychosom Med 67(Suppl 1): S34–S36

12.

Carota A, Berney A, Aybek S et al. (2005) A prospective study of predictors of poststroke depression. Neurology 64: 428–433PubMed

13.

Carson AJ, MacHale S, Allen K et al. (2000) Depression after stroke and lesion location: a systematic review. Lancet 356(9224): 122–126CrossRefPubMed

14.

Cassidy EM, Walsh MT, O’Connor R et al. (2003) Platelet surface glycoprotein expression in poststroke depression: a preliminary study. Psychiatry Res 118(2): 175–181CrossRefPubMed

15.

Choi-Kwon S, Han SW, Kwon SU et al. (2006) Fluoxetine treatment in poststroke depression, emotional incontinence and anger proneness. A double-blind, placebo-controlled study. Stroke 37(1): 156–161CrossRefPubMed

16.

Currier MB, Murray GB, Welch CC (1992) Electroconvulsive therapy for poststroke depressed geriatric patients. J Neuropsychiatry Clin Neurosci 4(2): 140–144PubMed

17.

Dam H, Pedersen HE, Ahlgren P (1989) Depression among patients with stroke. Acta Psychiatr Scand 80(2): 118–124PubMed

18.

Dantendorfer K, Amering M, Prayer D et al. (1996) Treatment of Koro and panic attacks after stroke. Anxiety 2(1): 53–55CrossRefPubMed

19.

Dean CE (2004) Mortality and poststroke depression. Am J Psychiatry 161(8): 1506CrossRef

20.

Deuschle M, Lederbogen F (2002) Depression und koronare Herzerkrankung: pathogenetische Faktoren vor dem Hintergrund des Stresskonzeptes. Fortschr Neurol Psychiatr 70: 268–275CrossRefPubMed

21.

Dieguez S, Staub F, Bruggimann L et al. (2004) Is poststroke depression a vascular depression? J Neurol Sci 226: 53–58CrossRefPubMed

22.

Endres M, Fan G, Hirt L et al. (2000) Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. J Cereb Blood Flow Metab 20(1): 139–144CrossRefPubMed

23.

Everson SA, Roberts RE, Goldberg DE et al. (1998) Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 158(10): 1133–1138CrossRefPubMed

24.

Fedoroff JP, Starkstein SE, Parikh RM et al. (1991) Are depressive symptoms nonspecific in patients with acute stroke? Am J Psychiatry 148(9): 1172–1176PubMed

25.

Ferketich AK, Ferguson JP, Binkley PF (2005) Depressive symptoms and inflammation among heart failure patients. Am Heart J 150(1): 132–136CrossRefPubMed

26.

Folstein MF, Maiberger R, McHugh PR (1977) Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 40(10): 1018–1020PubMed

27.

Fruehwald S, Gatterbauer E, Rehak P et al. (2003) Early fluoxetine treatment of poststroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow-up. J Neurol 250(3): 347–351CrossRefPubMed

28.

Gass P, Reichardt HM, Strekalova T et al. (2001) Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety? Physiol Behav 73(5): 811–825CrossRefPubMed

29.

Ghose SS, Williams LS, Swindle RW (2005) Depression and other mental health diagnoses after stroke increase inpatient and outpatient medical utilization three years poststroke. Med Care 43(12): 1259–1264CrossRefPubMed

30.

Hackett ML, Anderson CS (2005) Predictors of depression after stroke: a systematic review of observational studies. Stroke 36(10): 2296–2301CrossRefPubMed

31.

Hackett ML, Anderson CS, House AO (2005) Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 36(5): 1098–1103CrossRefPubMed

32.

Herrmann N, Black SE, Lawrence J et al. (1998) The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke 29(3): 618–624PubMed

33.

Hickie I, Scott E, Mitchell P et al. (1995) Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37(3): 151–160CrossRefPubMed

34.

Huff W, Steckel R, Sitzer M (2003) Poststroke depression: risk factors and effects on the course of the stroke. Nervenarzt 74(2): 104–114CrossRefPubMed

35.

Jonas BS, Mussolino ME (2000) Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 62(4): 463–471PubMed

36.

Jorge RE, Robinson RG, Arndt S et al. (2003) Mortality and poststroke depression: a placebo-controlled trial of antidepressant. Am J Psychiatry 160(10): 1823–1829CrossRefPubMed

37.

Jorge RE, Robinson RG, Tateno A et al. (2004) Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 55(4): 398–405CrossRefPubMed

38.

Kotila M, Numminen H, Waltimo O et al. (1998) Depression after stroke: results of the FINNSTROKE study. Stroke 29(2): 368–372PubMed

39.

Larson SL, Owens PL, Ford D et al. (2001) Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 32(9): 1979–1983PubMed

40.

Lesser IM, Boone KB, Mehringer CM et al. (1996) Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 153(10): 1280–1287PubMed

41.

Malberg JE, Eisch AJ, Nestler EJ et al. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24): 9104–9110PubMed

42.

Maricle RA, Sennhauser S, Burry M (1991) Panic disorder associated with right parahippocampal infarction. J Nerv Ment Dis 179(6): 374–375PubMed

43.

Mayo NE, Korner-Bitensky NA, Becker R (1991) Recovery time of independent function poststroke. Am J Phys Med Rehabil 70(1): 5–12PubMed

44.

Mimura M, Nakagome K, Hirashima N et al. (2005) Left frontotemporal hyperperfusion in a patient with poststroke mania. Psychiatry Res 139(3): 263–267PubMed

45.

Morris PL, Raphael B, Robinson RG (1992) Clinical depression is associated with impaired recovery from stroke. Med J Aust 157(4): 239–242PubMed

46.

Morris PL, Robinson RG, Andrzejewski P et al. (1993) Association of depression with 10-year poststroke mortality. Am J Psychiatry 150(1): 124–129PubMed

47.

Murray GB, Shea V, Conn DK (1986) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47(5): 258–260PubMed

48.

Murray V, von Arbin M, Bartfai A et al. (2005) Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 66(6): 708–716PubMed

49.

Nagaratnam N, Wong KK, Patel I (2006) Secondary mania of vascular origin in elderly patients: A report of two clinical cases. Arch Gerontol Geriatr (in press)

50.

Narushima K, Kosier JT, Robinson RG (2002) Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 190(5): 296–303CrossRefPubMed

51.

Narushima K, Kosier JT, Robinson RG (2003) A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 15(4): 422–430PubMed

52.

Nestler EJ, Gould E, Manji H et al. (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52(6): 503–528CrossRefPubMed

53.

Neu P, Schlattmann P, Schilling A et al. (2004) Cerebrovascular reactivity in major depression: a pilot study. Psychosom Med 66(1): 6–8CrossRefPubMed

54.

Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15(11): 7539–7547PubMed

55.

Niedermaier N, Bohrer E, Schulte K et al. (2004) Prevention of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 65(12): 1619–1623PubMed

56.

Nilsson FM, Kessing LV (2004) Increased risk of developing stroke for patients with major affective disorder—a registry study. Eur Arch Psychiatry Clin Neurosci 254(6): 387–391CrossRefPubMed

57.

Nys GM, van Zandvoort MJ, van der Worp HB et al. (2005) Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. J Neurol Sci 228(1): 27–33CrossRefPubMed

58.

Ohira T, Iso H, Satoh S et al. (2001) Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 32(4): 903–908PubMed

59.

Ostir GV, Markides KS, Peek MK et al. (2001) The association between emotional well-being and the incidence of stroke in older adults. Psychosom Med 63(2): 210–215PubMed

60.

Palomaki H, Kaste M, Berg A et al. (1999) Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 66(4): 490–494PubMed

61.

Paolucci S, Antonucci G, Grasso MG et al. (2001) Poststroke depression, anti-depressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis 12(3): 264–271CrossRefPubMed

62.

Paolucci S, Gandolfo C, Provinciali L et al. (2005) Quantification of the risk of post stroke depression: the Italian multicenter observational study DESTRO. Acta Psychiatr Scand 112(4): 272–278CrossRefPubMed

63.

Paradiso S, Robinson RG (1999) Minor depression after stroke: an initial validation of the DSM-IV construct. Am J Geriatr Psychiatry 7(3): 244–251PubMed

64.

Post F (1972) The management and nature of depressive illnesses in late life: a follow-through study. Br J Psychiatry 121(563): 393–404PubMed

65.

Rasmussen A, Lunde M, Poulsen DL et al. (2003) A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 44(3): 216–221CrossRefPubMed

66.

Robinson RG (2005) Vascular depression and poststroke depression. Where do we go from here? Am J Geriatr Psychiatry 13(2): 85–87CrossRefPubMed

67.

Santarelli L, Saxe M, Gross C et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634): 805–809CrossRefPubMed

68.

Simons LA, McCallum J, Friedlander Y et al. (1998) Risk factors for ischemic stroke: dubbo study of the elderly. Stroke 29(7): 1341–1346PubMed

69.

Singh A, Black SE, Herrmann N et al. (2000) Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke 31(3): 637–644PubMed

70.

Sinyor D, Jacques P, Kaloupek DG et al. (1986) Poststroke depression and lesion location. An attempted replication. Brain 109(Pt 3): 537–546

71.

Spencer KA, Tompkins CA, Schulz R (1997) Assessment of depression in patients with brain pathology: the case of stroke. Psychol Bull 122(2): 132–152CrossRefPubMed

72.

Starkstein SE, Fedoroff JP, Price TR et al. (1992) Anosognosia in patients with cerebrovascular lesions. A study of causative factors. Stroke 23(10): 1446–1453PubMed

73.

Steffens DC, Conway CR, Dombeck CB et al. (2001) Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. J ECT 17: 45–49CrossRefPubMed

74.

Tang WK, Ungvari GS, Chiu HF et al. (2002) Psychiatric morbidity in first time stroke patients in Hong Kong: a pilot study in a rehabilitation unit. Aust N Z J Psychiatry 36(4): 544–549CrossRefPubMed

75.

Thomas AJ, O’Brien JT, Davis S et al. (2002) Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 59(9): 785–792CrossRefPubMed

76.

Thomas AJ, Perry R, Kalaria RN et al. (2003) Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 18(1): 7–13CrossRefPubMed

77.

Thomas AJ, Kalaria RN, O’Brien JT (2004) Depression and vascular disease: what is the relationship? J Affect Disord 79(1–3): 81–95

78.

Toso V, Gandolfo C, Paolucci S et al. (2004) Poststroke depression: research methodology of a large multicentre observational study (DESTRO). Neurol Sci 25(3): 138–144CrossRefPubMed

79.

Tupler LA, Krishnan KR, McDonald WM et al. (2002) Anatomic location and laterality of signal hyperintensities in late-life depression. J Psychosom Res 53(2): 665–676CrossRefPubMed

80.

Whyte EM, Mulsant BH (2002) Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 52: 253–264CrossRefPubMed

81.

Wiart L, Petit H, Joseph PA et al. (2000) Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 31(8): 1829–1832PubMed

82.

Williams LS (2005) Depression and stroke: cause or consequence? Semin Neurol 25(4): 396–409CrossRefPubMed

83.

Williams LS, Ghose SS, Swindle RW (2004) Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 161(6): 1090–1095CrossRefPubMed

84.

Winter B, Juckel G, Victorov I et al. (2005) Anxious and hyperactive phenotype following brief ischemic episodes in mice. Biol Psychiatry 57(10): 1166–1175CrossRefPubMed

85.

Burvill PW, Johnson GA, Jamrozik KD et al. (1995) Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry 166(3): 320-327PubMed

86.

Pohjasvaara T,Leppavuori A, Siira I et al. (1998) Frequency and clinical determinants of poststroke depression. Stroke 29(11): 2311-2317PubMed

87.

Kauhanen M, Korpelainen JT, Hiltunen P et al. (1999) Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 30(9): 1875-1880PubMed

88.

Astrom M, Adolfsson R, Asplund K (1993) Major depression in stroke patients. A 3-year longitudinal study. Stroke 24(7): 976-982PubMed

Titel: Poststroke-Depression
Klinik, Epidemiologie, Therapie, pathophysiologische Konzepte
verfasst von: G. Kronenberg
J. Katchanov
Prof. Dr. M. Endres
Publikationsdatum: 01.10.2006
Verlag: Springer-Verlag
Erschienen in: Der Nervenarzt / Ausgabe 10/2006
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI: https://doi.org/10.1007/s00115-006-2130-y

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Poststroke-Depression

Klinik, Epidemiologie, Therapie, pathophysiologische Konzepte

Zusammenfassung

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2006

Mitteilungen der DGPPN 10/06

Therapierefraktärer Status epilepticus

Zentrale und periphere Deafferenzierungsschmerzen

Bilaterale Halsarteriendissektion bei herznaher Aortendissektion

Long-QT-Syndrom als Differenzialdiagnose einer Grand-Mal-Epilepsie

Schlaf bei neurodegenerativen Erkrankungen

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein